USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Tecres S.P.A.

USPTO PatentsView assignee record - 34 granted patents across 14 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Tecres ranks #9,388 of 49,997 tracked US assignees by granted-patent volume, with 34 patents across 14 technology areas.

#9,388
of 49,997 US assignees by volume
Top 45%
by Innovation Score (36.9/100)
16.6
avg claims per patent
-45%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9388 · Foreign Corporation #9,388 · 34 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 34 grants
  • UPPER-Q #9,388/49,997
  • PHOTO-FINISH Shoals Group
  • CPC-FOCUS A61F · 14 areas
  • INNOV-THIN 36.9/100
  • CLAIMS-RICH 16.6 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -45% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Shoals Technologies Group, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Tecres’s 36.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Tecres

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Tecres's Innovation Score is 36.9/100 (top 45% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Tecres?

Each dot is one of Tecres’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Tecres’s own 16.6 claims/patent is ABOVE the 12.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Tecres vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 33.934.034.03434.034.034.1 81012141618 Granted patents (volume) Avg claims / patent Shoals Technologies Group, LLC - 34, 11.47Shoals GroupSolexel, Inc. - 34, 17.59SolexelTake-two Interactive Software, Inc. - 34, 16.38Take-two Interact…Taptext LLC - 34, 11.06TaptextTI Automotive Technology Center GMBH - 34, 14.18TI Automotive Tec…Tidi Products, LLC - 34, 12.12Tidi ProductsToyo Engineering Corporation - 34, 9.47Toyo EngineeringTechnische Universität Darmstadt - 34, 15.12Technische Univer…Tecres S.P.A. - 34, 16.62Tecres S P A
Tecres vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Tecres's grants concentrate

Tecres S.P.A. is a focused PatentsView assignee: 14 CPC subclasses with 55.9% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2015 (6 grants) versus a trough of 3 in 2018. By volume, Tecres sits between Shoals Technologies Group, LLC and Technische Universität Darmstadt.

Tecres's three-year grant acceleration

Tecres S.P.A. shows 3 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Tecres's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Tecres holds 34 patents at rank #9,387, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Tecres

By rank, the assignees closest to #9,387 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Tecres's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Tecres, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Tecres ranks #347 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (37 here).

Tecres's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 45% higher than 55% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

234567 20152016201720182019202020212024 3
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Tecres S.P.A. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 6 17.6%
2016 4 11.8%
2017 4 11.8%
2018 3 8.8%
2019 5 14.7%
2020 4 11.8%
2021 5 14.7%
2024 3 8.8%

Which technologies does Tecres S.P.A. patent most?

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Tecres S.P.A.'s patent record in context - here's where to go next.

  • Tecres S.P.A.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 55.9% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #9,388 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Tecres S.P.A. against Shoals Technologies Group, LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 36.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.